Form 4: Intuitive Surgical CFO's Equity Vesting and Tax Withholding

Intuitive Surgical's EVP & CFO, Jamie Samath, reported the vesting and conversion of Restricted and Performance Stock Units into common stock, alongside related tax withholdings.

Summary

• Jamie Samath, EVP & CFO & Enterprise Technology at Intuitive Surgical Inc. (ISRG), reported changes in beneficial ownership.
• On February 28, 2026, 752 shares of common stock were acquired through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.0.
• Concurrently, 373 shares of common stock were disposed of at a price of $503.51 to cover statutory tax withholding requirements related to the RSU vesting.
• An additional 10,773 shares of common stock were acquired on February 28, 2026, from the vesting of Performance Stock Units (PSUs) at an exercise price of $0.0.
• 5,343 shares of common stock were disposed of at a price of $503.51 to cover taxes applicable to the settlement of these PSUs.
• Following these transactions, Jamie Samath beneficially owns 15,366 shares of common stock directly.
• The PSUs were initially granted on February 28, 2023, with performance criteria achieved as determined by the Compensation Committee, and vested on February 28, 2026.
• RSUs vest 25% per year over a four-year period, commencing on the first anniversary of the grant date, converting to common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine event. It reflects the successful vesting of executive equity awards, indicating performance achievement and continued executive alignment with company interests, without introducing new material information.

Positives

• The vesting of Performance Stock Units indicates that the company's Compensation Committee determined that certain performance metrics were achieved, reflecting positively on company performance.
• The conversion of RSUs and PSUs into common stock aligns executive interests with shareholder value, promoting retention and long-term commitment.

Negatives

• A significant portion of vested shares (373 from RSUs and 5,343 from PSUs) were withheld to cover statutory tax obligations, reducing the net shares received by the executive.

Future Outlook

The filing does not contain forward-looking statements or guidance, as it is a report of past executive compensation transactions.

Industry Context

StockSavvy.ai notes that these transactions represent routine executive compensation events, specifically the vesting of equity awards, which are a common component of compensation packages across the medical device and technology industries. Such events are standard practice for aligning executive incentives with long-term company performance and shareholder interests.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) as a significant component of executive compensation is a widely adopted practice across the S&P 500 and particularly prevalent in high-growth technology and healthcare sectors, including companies like Medtronic (MDT) and Johnson & Johnson (JNJ).
• The vesting schedules (e.g., 25% annually over four years for RSUs, three-year vesting for PSUs contingent on performance) are consistent with typical industry benchmarks designed to promote executive retention and long-term strategic alignment.
• The practice of withholding shares to cover statutory tax obligations upon vesting is a standard and efficient mechanism for managing executive tax liabilities in equity compensation plans, mirroring practices seen at comparable firms.

Stakeholder Impact

• Shareholders: The vesting of PSUs indicates that performance targets were met, which is generally positive for shareholders. The transactions also demonstrate continued alignment of executive incentives with shareholder value.
• Employees: The compensation structure, including equity awards, can serve as a benchmark for other employees' long-term incentive plans.

Key Dates

Recommendation

This Form 4 reports routine executive compensation events, specifically the vesting of pre-scheduled Restricted Stock Units and Performance Stock Units, along with associated tax withholdings. It does not contain new material information that would fundamentally alter the investment thesis for Intuitive Surgical. These transactions are expected and do not signal discretionary buying or selling based on new insights, thus a 'hold' recommendation is appropriate as it provides no new catalyst for a change in stock valuation.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Restricted Stock Units, Performance Stock Units, Executive Compensation, Stock Vesting, Tax Withholding